Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Originalarbeit (Zeitschrift)

** Adelsmayr, G; Haidmayer, A; Spreizer, C; Janisch, M; Quehenberger, F; Klocker, E; Graninger, W; Fuchsjäger, M; Hermann, J The value of MRI compared to conventional radiography in analysing morphologic changes in the spine in axial spondyloarthritis.
Insights Imaging. 2021; 12(1): 183 Doi: 10.1186/s13244-021-01127-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Barth, DA; Sareban, N; Lindner, AK; Daller, LAJ; Matzhold, EM; Hutterer, G; Smolle, M; Mischinger, J; Riedl, JM; Seles, M; Mannweiler, S; Bauernhofer, T; Pummer, K; Pichler, R; Zigeuner, R; Schlenke, P; Pichler, M Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-up.
Urol Oncol. 2021; 39(10):736.e9-736.e16 Doi: 10.1016/j.urolonc.2021.06.005 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Br J Cancer. 2021; 124(11): 1795-1802. Doi: 10.1038/s41416-021-01284-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Barz, M; Aftahy, K; Janssen, I; Ryang, YM; Prokop, G; Combs, SE; Jost, PJ; Meyer, B; Gempt, J Spinal Manifestation of Malignant Primary (PLB) and Secondary Bone Lymphoma (SLB).
CURR ONCOL. 2021; 28(5): 3891-3899. Doi: 10.3390/curroncol28050332 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Berg, JL; Perfler, B; Hatzl, S; Mayer, MC; Wurm, S; Uhl, B; Reinisch, A; Klymiuk, I; Tierling, S; Pregartner, G; Bachmaier, G; Berghold, A; Geissler, K; Pichler, M; Hoefler, G; Strobl, H; Wölfler, A; Sill, H; Zebisch, A Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Clin Epigenetics. 2021; 13(1): 1-1. Doi: 10.1186/s13148-020-00979-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Berger, M; Thueringer, A; Franz, D; Dandachi, N; Talakić, E; Richtig, G; Richtig, E; Rohrer, PM; Koch, L; Wolf, IH; Koch, C; Rainer, BM; Koeller, M; Pichler, M; Gerritsmann, H; Kashofer, K; Aigelsreiter, A Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing-A Prospective Feasibility Study.
Cancers (Basel). 2021; 13(12): Doi: 10.3390/cancers13123101 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Beyer, J; Collette, L; Sauvé, N; Daugaard, G; Feldman, DR; Tandstad, T; Tryakin, A; Stahl, O; Gonzalez-Billalabeitia, E; De, Giorgi, U; Culine, S; de, Wit, R; Hansen, AR; Bebek, M; Terbuch, A; Albany, C; Hentrich, M; Gietema, JA; Negaard, H; Huddart, RA; Lorch, A; Cafferty, FH; Heng, DYC; Sweeney, CJ; Winquist, E; Chovanec, M; Fankhauser, C; Stark, D; Grimison, P; Necchi, A; Tran, B; Heidenreich, A; Shamash, J; Sternberg, CN; Vaughn, DJ; Duran, I; Bokemeyer, C; Patrikidou, A; Cathomas, R; Assele, S; Gillessen, S, , International, Germ, Cell, Cancer, Classification, Update, Consortium Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
J Clin Oncol. 2021; 39(14):1553-1562 Doi: 10.1200/JCO.20.03292 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Brčić, I; Godschachner, TM; Bergovec, M; Igrec, J; Till, H; Lackner, H; Scheipl, S; Kashofer, K; Brodowicz, T; Leithner, A; Szkandera, J; Liegl-Atzwanger, B Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions.
Mod Pathol. 2021; 34(2):396-407 Doi: 10.1038/s41379-020-00657-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Chapel, DB; Schulte, JJ; Absenger, G; Attanoos, R; Brcic, L; Butnor, KJ; Chirieac, L; Churg, A; Galateau-Sallé, F; Hiroshima, K; Hung, YP; Kindler, H; Krausz, T; Marchevsky, A; Mino-Kenudson, M; Mueller, J; Nabeshima, K; Turaga, K; Walts, AE; Husain, AN Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases.
Mod Pathol. 2021; 34(2):380-395 Doi: 10.1038/s41379-020-00688-4
Web of Science PubMed FullText FullText_MUG

 

** Dandachi, N; Posch, F; Graf, R; Suppan, C; Klocker, EV; Müller, HD; Lindenmann, J; Terbuch, A; Heitzer, E; Balic, M Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR⁺ breast cancer patients undergoing CDK4/6 treatment.
Mol Oncol. 2021; 15(9):2390-2400 Doi: 10.1002/1878-0261.12870 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dengler, MA; Gibson, L; Adams, JM BAX mitochondrial integration is regulated allosterically by its α1-α2 loop.
Cell Death Differ. 2021; 28(12):3270-3281 Doi: 10.1038/s41418-021-00815-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Filipits, M; Rudas, M; Singer, CF; Fitzal, F; Bago-Horvath, Z; Greil, R; Balic, M; Lax, SF; Halper, S; Hulla, W; Wu, NC; Liu, X; Weidler, J; Bates, M; Hlauschek, D; Gnant, M; Dubsky, P ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
ESMO Open. 2021; 6(4): 100228 Doi: 10.1016/j.esmoop.2021.100228 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fitzal, F; Filipits, M; Fesl, C; Rudas, M; Greil, R; Balic, M; Moinfar, F; Herz, W; Dubsky, P; Bartsch, R; Ferree, S; Schaper, C; Gnant, M; Austrian Breast and Colorectal Cancer Study Group (ABCSG) PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.
Br J Surg. 2021; 108(3): 308-314. Doi: 10.1093/bjs/znaa089 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gampenrieder, SP; Pircher, M; Fesl, C; Rinnerthaler, G; Mlineritsch, B; Greil-Ressler, S; Steger, GG; Sagaster, V; Fitzal, F; Exner, R; Devyatko, Y; Balic, M; Stoger, H; Suppan, C; Bauernhofer, T; Singer, CF; Pfeiler, G; Seifert, M; Helfgott, R; Heck, D; Rumpold, H; Kwasny, W; Wieder, U; Gnant, M; Greil, R Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)
BREAST CARE. 2021; Doi: 10.1159/000516157
Web of Science FullText FullText_MUG

 

** Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, A; Balic, M; Heibl, S; Schmitt, C; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Hager, C; Andel, J; Hubalek, M; Knauer, M; Greil, R Landscape of HER2-low metastatic breast cancer (MBC): results from the Austrian AGMT_MBC-Registry.
BREAST CANCER RES. 2021; 23(1): 112 Doi: 10.1186/s13058-021-01492-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Geiger-Gritsch, S; Olschewski, H; Kocher, F; Wurm, R; Absenger, G; Flicker, M; Hermann, A; Heininger, P; Fiegl, M; Zechmeister, M; Endel, F; Wild, C; Pall, G Real-world experience with anti-PD-1/PD-L1 monotherapy in patients with non-small cell lung cancer : A retrospective Austrian multicenter study.
Wien Klin Wochenschr. 2021; 133(21-22):1122-1130 Doi: 10.1007/s00508-021-01940-w
Web of Science PubMed FullText FullText_MUG

 

** Gillessen, S; Sauvé, N; Collette, L; Daugaard, G; de, Wit, R; Albany, C; Tryakin, A; Fizazi, K; Stahl, O; Gietema, JA; De, Giorgi, U; Cafferty, FH; Hansen, AR; Tandstad, T; Huddart, RA; Necchi, A; Sweeney, CJ; Garcia-Del-Muro, X; Heng, DYC; Lorch, A; Chovanec, M; Winquist, E; Grimison, P; Feldman, DR; Terbuch, A; Hentrich, M; Bokemeyer, C; Negaard, H; Fankhauser, C; Shamash, J; Vaughn, DJ; Sternberg, CN; Heidenreich, A; Beyer, J, , International, Germ, Cell, Cancer, Classification, Update, Consortium Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
J Clin Oncol. 2021; 39(14):1563-1574 Doi: 10.1200/JCO.20.03296 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Fitzal, F; Rinnerthaler, G; Steger, GG; Greil-Ressler, S; Balic, M; Heck, D; Jakesz, R; Thaler, J; Egle, D; Manfreda, D; Bjelic-Radisic, V; Wieder, U; Singer, CF; Melbinger-Zeinitzer, E; Haslbauer, F; Sevelda, P; Trapl, H; Wette, V; Wimmer, K; Gampenrieder, SP; Bartsch, R; Kacerovsky-Strobl, S; Suppan, C; Brunner, C; Deutschmann, C; Soelkner, L; Fesl, C; Greil, R, , Austrian, Breast, and, Colorectal, Cancer, Study, Group;Austrian, Breast, and, Colorectal, Cancer, Study, Group Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med. 2021; 385(5):395-405 Doi: 10.1056/NEJMoa2104162
Web of Science PubMed FullText FullText_MUG

 

** Grilz, E; Posch, F; Nopp, S; Königsbrügge, O; Lang, IM; Klimek, P; Thurner, S; Pabinger, I; Ay, C Relative risk of arterial and venous thromboembolism in persons with cancer vs. persons without cancer-a nationwide analysis.
Eur Heart J. 2021; 42(23): 2299-2307. Doi: 10.1093/eurheartj/ehab171
Web of Science PubMed FullText FullText_MUG

 

** Grübler, MR; Zittermann, A; Verheyen, ND; Trummer, C; Theiler-Schwetz, V; Keppel, MH; Malle, O; Richtig, G; Gängler, S; Bischoff-Ferrari, H; Scharnagl, H; Meinitzer, A; März, W; Tomaschitz, A; Pilz, S Randomized trial of vitamin D versus placebo supplementation on markers of systemic inflammation in hypertensive patients.
Nutr Metab Cardiovasc Dis. 2021; 31(11):3202-3209 Doi: 10.1016/j.numecd.2021.07.028
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621 Doi: 10.1097/HS9.0000000000000621 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207 Doi: 10.1007/s00520-021-06059-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Posch, F; Sareban, N; Stradner, M; Rosskopf, K; Reisinger, AC; Eller, P; Schörghuber, M; Toller, W; Sloup, Z; Prüller, F; Gütl, K; Pilz, S; Rosenkranz, AR; Greinix, HT; Krause, R; Schlenke, P; Schilcher, G Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Ann Intensive Care. 2021; 11(1): 73 Doi: 10.1186/s13613-021-00867-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Reisinger, AC; Posch, F; Prattes, J; Stradner, M; Pilz, S; Eller, P; Schoerghuber, M; Toller, W; Gorkiewicz, G; Metnitz, P; Rief, M; Prüller, F; Rosenkranz, AR; Valentin, T; Krause, R; Hoenigl, M; Schilcher, G Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Crit Care. 2021; 25(1): 335 Doi: 10.1186/s13054-021-03753-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Horak, P; Heining, C; Kreutzfeldt, S; Hutter, B; Mock, A; Hüllein, J; Fröhlich, M; Uhrig, S; Jahn, A; Rump, A; Gieldon, L; Möhrmann, L; Hanf, D; Teleanu, V; Heilig, CE; Lipka, DB; Allgäuer, M; Ruhnke, L; Laßmann, A; Endris, V; Neumann, O; Penzel, R; Beck, K; Richter, D; Winter, U; Wolf, S; Pfütze, K; Geörg, C; Meißburger, B; Buchhalter, I; Augustin, M; Aulitzky, WE; Hohenberger, P; Kroiss, M; Schirmacher, P; Schlenk, RF; Keilholz, U; Klauschen, F; Folprecht, G; Bauer, S; Siveke, JT; Brandts, CH; Kindler, T; Boerries, M; Illert, AL; von, Bubnoff, N; Jost, PJ; Spiekermann, K; Bitzer, M; Schulze-Osthoff, K; von, Kalle, C; Klink, B; Brors, B; Stenzinger, A; Schröck, E; Hübschmann, D; Weichert, W; Glimm, H; Fröhling, S Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers.
Cancer Discov. 2021; 11(11): 2780-2795. Doi: 10.1158/2159-8290.CD-21-0126
Web of Science PubMed FullText FullText_MUG

 

** Huemer, M; Jahn-Kuch, D; Hofmann, G; Andritsch, E; Farkas, C; Schaupp, W; Masel, EK; Jost, PJ; Pichler, M Trends and Patterns in the Public Awareness of Palliative Care, Euthanasia, and End-of-Life Decisions in 3 Central European Countries Using Big Data Analysis From Google: Retrospective Analysis.
J Med Internet Res. 2021; 23(9): e28635 Doi: 10.2196/28635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Illini, O; Hochmair, MJ; Fabikan, H; Weinlinger, C; Tufman, A; Swalduz, A; Lamberg, K; Hashemi, SMS; Huemer, F; Vikstrom, A; Wermke, M; Absenger, G; Addeo, A; Banerji, S; Calles, A; Clarke, S; Di Maio, M; Durand, A; Duruisseaux, M; Itchins, M; Kaaranien, OS; Krenn, F; Laack, E; de Langen, AJ; Mohorcic, K; Pall, G; Passaro, A; Prager, G; Rittmeyer, A; Rothenstein, J; Schumacher, M; Woll, E; Valipour, A Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program
THER ADV MED ONCOL. 2021; 13: 17588359211019675 Doi: 10.1177/17588359211019675 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Laprovitera, N; Riefolo, M; Porcellini, E; Durante, G; Garajova, I; Vasuri, F; Aigelsreiter, A; Dandachi, N; Benvenuto, G; Agostinis, F; Sabbioni, S; Berindan, Neagoe, I; Romualdi, C; Ardizzoni, A; Trerè, D; Pichler, M; D'Errico, A; Ferracin, M MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
Mol Oncol. 2021; 15(10):2732-2751 Doi: 10.1002/1878-0261.13026 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mirzaei, S; Lipp, R; Zandieh, S; Leisser, A Single-Center Comparison of [Cu-64]-DOTAGA-PSMA and [F-18]-PSMA PET-CT for Imaging Prostate Cancer
CURR ONCOL. 2021; 28(5): 4167-4173. Doi: 10.3390/curroncol28050353 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mollnar, S; Pondorfer, P; Kasparek, AK; Reinisch, S; Moik, F; Stotz, M; Halm, M; Szkandera, J; Terbuch, A; Eisner, F; Gerger, A; Kapp, KS; Partl, R; Vasicek, S; Weiland, T; Pichler, M; Stöger, H; Thurnher, D; Posch, F Decrease in treatment intensity predicts worse outcome in patients with locally advanced head and neck squamous cell carcinoma undergoing radiochemotherapy.
Clin Transl Oncol. 2021; 23(3):543-553 Doi: 10.1007/s12094-020-02447-y [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Müller, M; Posch, F; Kiem, D; Barth, D; Horvath, L; Stotz, M; Schaberl-Moser, R; Pichler, M; Greil, R; Jost, PJ; Seeber, A; Amann, A; Schlick, K; Gerger, A; Riedl, JM Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis.
Ther Adv Med Oncol. 2021; 13: 17588359211039930 Doi: 10.1177/17588359211039930 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Odinius, TO; Buschhorn, L; Wagner, C; Hauch, RT; Dill, V; Dechant, M; Buck, MC; Shoumariyeh, K; Moog, P; Schwaab, J; Reiter, A; Brockow, K; Götze, K; Bassermann, F; Höckendorf, U; Branca, C; Jost, PJ; Jilg, S Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies.
J CANCER RES CLIN. 2021; Doi: 10.1007/s00432-021-03827-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, M; Steyrer, J Cost-effectiveness analysis of the use of immunotherapy in metastatic solid tumours in Austria by applying the ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) version 1.1.
ESMO Open. 2021; 6(4): 100198 Doi: 10.1016/j.esmoop.2021.100198 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pink, D; Andreou, D; Bauer, S; Brodowicz, T; Kasper, B; Reichardt, P; Richter, S; Lindner, LH; Szkandera, J; Gruenwald, V; Kebenko, M; Kirchner, M; Hohenberger, P Treatment of Angiosarcoma with Pazopanib and Paclitaxel: Results of the EVA (Evaluation of Votrient(R) in Angiosarcoma) Phase II Trial of the German Interdisciplinary Sarcoma Group (GISG-06)
CANCERS. 2021; 13(6): 1223 Doi: 10.3390/cancers13061223 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Cancers (Basel). 2021; 13(16): Doi: 10.3390/cancers13163996 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch-Pertl, L; Weger, M; Pinter-Hausberger, S; List, W; Posch, F; Wedrich, A; Michelitsch, K; Kozma, MO; Woltsche, N; Binder, CJ SERUM LEVELS OF ANTIBODIES AGAINST OXIDATION-SPECIFIC EPITOPES ARE DECREASED IN PATIENTS WITH RETINAL VEIN OCCLUSION.
Retina. 2021; 41(6):1193-1201 Doi: 10.1097/IAE.0000000000003001
Web of Science PubMed FullText FullText_MUG

 

** Prager, GW; Oehler, L; Gerger, A; Mlineritsch, B; Andel, J; Petzer, A; Wilthoner, K; Sliwa, T; Pichler, P; Winder, T; Heibl, S; Gruenberger, B; Laengle, F; Hubmann, E; Korger, M; Pecherstorfer, M; Djanani, A; Neumann, HJ; Philipp-Abbrederis, K; Wöll, E; Trondl, R; Arnold-Schrauf, C; Eisterer, W Comparison of nab-paclitaxel plus gemcitabine in elderly versus younger patients with metastatic pancreatic cancer: Analysis of a multicentre, prospective, non-interventional study.
Eur J Cancer. 2021; 143:101-112 Doi: 10.1016/j.ejca.2020.11.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reisinger, AC; Niedrist, T; Posch, F; Hatzl, S; Hackl, G; Prattes, J; Schilcher, G; Meißl, AM; Raggam, RB; Herrmann, M; Eller, P Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
Sci Rep. 2021; 11(1): 17476 Doi: 10.1038/s41598-021-96352-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reisinger, AC; Posch, F; Hackl, G; Marsche, G; Sourij, H; Bourgeois, B; Eller, K; Madl, T; Eller, P Branched-Chain Amino Acids Can Predict Mortality in ICU Sepsis Patients.
Nutrients. 2021; 13(9): Doi: 10.3390/nu13093106 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Hasenleithner, SO; Pregartner, G; Scheipner, L; Posch, F; Groller, K; Kashofer, K; Jahn, SW; Bauernhofer, T; Pichler, M; Stöger, H; Berghold, A; Hoefler, G; Speicher, MR; Heitzer, E; Gerger, A Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Ther Adv Med Oncol. 2021; 13:1758835920987658 Doi: 10.1177/1758835920987658 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Posch, F; Horvath, L; Gantschnigg, A; Renneberg, F; Schwarzenbacher, E; Moik, F; Barth, DA; Rossmann, CH; Stotz, M; Schaberl-Moser, R; Pichler, M; Stöger, H; Greil, R; Djanani, A; Schlick, K; Gerger, A Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis.
Eur J Cancer. 2021; 151: 3-13. Doi: 10.1016/j.ejca.2021.03.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Hubalek, M; Petru, E; Sandholzer, M; Andel, J; Balic, M; Melchardt, T; Hauser-Kronberger, C; Schmitt, CA; Ulmer, H; Greil, R Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).
Ther Adv Med Oncol. 2021; 13: 17588359211042301 Doi: 10.1177/17588359211042301 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipl, S; Brcic, I; Moser, T; Fischerauer, S; Riedl, J; Bergovec, M; Smolle, M; Posch, F; Gerger, A; Pichler, M; Stoeger, H; Leithner, A; Heitzer, E; Liegl-Atzwanger, B; Szkandera, J Molecular profiling of soft-tissue sarcomas with FoundationOne^® Heme identifies potential targets for sarcoma therapy: a single-centre experience.
Ther Adv Med Oncol. 2021; 13:17588359211029125 Doi: 10.1177/17588359211029125 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheipner, L; Smolle, MA; Barth, D; Posch, F; Stotz, M; Pichler, M; StÖger, H; Gerger, A; Riedl, JM The AST/ALT Ratio Is an Independent Prognostic Marker for Disease-free Survival in Stage II and III Colorectal Carcinoma.
Anticancer Res. 2021; 41(1):429-436 Doi: 10.21873/anticanres.14792
Web of Science PubMed FullText FullText_MUG

 

** Schrom, S; Hebesberger, T; Wallner, SA; Anders, I; Richtig, E; Brandl, W; Hirschmugl, B; Garofalo, M; Bernecker, C; Schlenke, P; Kashofer, K; Wadsack, C; Aigelsreiter, A; Heitzer, E; Riedl, S; Zweytick, D; Kretschmer, N; Richtig, G; Rinner, B MUG Mel3 Cell Lines Reflect Heterogeneity in Melanoma and Represent a Robust Model for Melanoma in Pregnancy.
Int J Mol Sci. 2021; 22(21): Doi: 10.3390/ijms222111318 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuehr, T; Kostner, S; Pichler, P; Jaeger, T; Kocher, F; Greil, R; Brodowicz, T Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Wien Klin Wochenschr. 2021; 133(1-2):21-25 Doi: 10.1007/s00508-019-01556-1
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Goda, M; Granegger, B; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; El-Heliebi, A; Pichler, M; Gerger, A; Posch, F; Tomberger, M; López-García, P; Feichtinger, J; Baumgartner, C; Leithner, A; Liegl-Atzwanger, B; Szkandera, J Influence of tumor-infiltrating immune cells on local control rate, distant metastasis, and survival in patients with soft tissue sarcoma.
Oncoimmunology. 2021; 10(1):1896658-1896658 Doi: 10.1080/2162402X.2021.1896658 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Herbsthofer, L; Granegger, B; Goda, M; Brcic, I; Bergovec, M; Scheipl, S; Prietl, B; Pichler, M; Gerger, A; Rossmann, C; Riedl, J; Tomberger, M; López-García, P; El-Heliebi, A; Leithner, A; Liegl-Atzwanger, B; Szkandera, J T-regulatory cells predict clinical outcome in soft tissue sarcoma patients: a clinico-pathological study.
Br J Cancer. 2021; 125(5):717-724 Doi: 10.1038/s41416-021-01456-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; van, de, Sande, M; Hayes, A; Bergovec, M; Smith, HG; Liegl-Atzwanger, B; Tunn, PU; Niethard, M; Windhager, R; Szkandera, J; Leithner, A, ;ESMO, Guidelines, Committee, EURACAN, and, GENTURIS Comparison of the 7th and 8th version of the AJCC classification system for soft tissue sarcomas of extremities and trunk in patients with localised, intermediate or high-grade disease treated at European tertiary sarcoma centres.
Eur J Surg Oncol. 2021; 47(8): 2182-2188. Doi: 10.1016/j.ejso.2021.03.252
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Posch, F; Mueller, HD; Mischitz, N; Steiner, D; Klocker, EV; Setaffy, L; Bargfrieder, U; Hammer, R; Hauser, H; Jost, PJ; Dandachi, N; Lax, S; Balic, M Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity.
Cancers (Basel). 2021; 13(10): Doi: 10.3390/cancers13102492 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Steiner, D; Klocker, EV; Posch, F; Henzinger, E; Muller, HD; Stoger, H; Dandachi, N; Balic, M Safety and Clinical Evaluation of Dual Inhibition with Pertuzumab and Trastuzumab Biosimilar SB3 in HER2-Positive Breast Cancer Patients
BREAST CARE. 2021; Doi: 10.1159/000513766 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Thijssen, R; Diepstraten, ST; Moujalled, D; Chew, E; Flensburg, C; Shi, MX; Dengler, MA; Litalien, V; MacRaild, S; Chen, M; Anstee, NS; Reljić, B; Gabriel, SS; Djajawi, TM; Riffkin, CD; Aubrey, BJ; Chang, C; Tai, L; Xu, Z; Morley, T; Pomilio, G; Bruedigam, C; Kallies, A; Stroud, DA; Bajel, A; Kluck, RM; Lane, SW; Schoumacher, M; Banquet, S; Majewski, IJ; Strasser, A; Roberts, AW; Huang, DCS; Brown, FC; Kelly, GL; Wei, AH Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.
Blood. 2021; 137(20): 2721-2735. Doi: 10.1182/blood.2020010167 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Tulchiner, G; Staudacher, N; Fritz, J; Hackl, M; Pichler, M; Seles, M; Shariat, SF; D'Andrea, D; Gust, K; Albrecht, W; Grubmüller, K; Madersbacher, S; Graf, S; Lusuardi, L; Augustin, H; Berger, A; Loidl, W; Horninger, W; Pichler, R Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria.
Cancers (Basel). 2021; 13(21): Doi: 10.3390/cancers13215377 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Unseld, M; Belic, J; Pierer, K; Zhou, Q; Moser, T; Bauer, R; Piringer, G; Gerger, A; Siebenhüner, A; Speicher, M; Heitzer, E; Prager, GW A higher ctDNA fraction decreases survival in regorafenib-treated metastatic colorectal cancer patients. Results from the regorafenib's liquid biopsy translational biomarker phase II pilot study.
Int J Cancer. 2021; 148(6):1452-1461 Doi: 10.1002/ijc.33303 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Valadez-Cosmes, P; Maitz, K; Kindler, O; Raftopoulou, S; Kienzl, M; Santiso, A; Mihalic, ZN; Brcic, L; Lindenmann, J; Fediuk, M; Pichler, M; Schicho, R; Houghton, AM; Heinemann, A; Kargl, J Identification of Novel Low-Density Neutrophil Markers Through Unbiased High-Dimensional Flow Cytometry Screening in Non-Small Cell Lung Cancer Patients.
Front Immunol. 2021; 12: 703846 Doi: 10.3389/fimmu.2021.703846 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Vigier, M; Thorson, KR; Andritsch, E; Stoeger, H; Suerth, L; Farkas, C; Schwerdtfeger, AR Physiological linkage during interactions between doctors and cancer patients.
Soc Sci Med. 2021; 284:114220 Doi: 10.1016/j.socscimed.2021.114220 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Vigier, M; Vigier, B; Andritsch, E; Schwerdtfeger, AR Cancer classification using machine learning and HRV analysis: preliminary evidence from a pilot study.
Sci Rep. 2021; 11(1): 22292 Doi: 10.1038/s41598-021-01779-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wahida, A; Müller, M; Hiergeist, A; Popper, B; Steiger, K; Branca, C; Tschurtschenthaler, M; Engleitner, T; Donakonda, S; De, Coninck, J; Öllinger, R; Pfautsch, MK; Müller, N; Silva, M; Usluer, S; Oberg, ET; Böttcher, JP; Pfarr, N; Anton, M; Slotta-Huspenina, JB; Nerlich, AG; Madl, T; Basic, M; Bleich, A; Berx, G; Ruland, J; Knolle, PA; Rad, R; Adolph, TE; Vandenabeele, P; Kanegane, H; Gessner, A; Jost, PJ; Yabal, M XIAP restrains TNF-driven intestinal inflammation and dysbiosis by promoting innate immune responses of Paneth and dendritic cells.
Sci Immunol. 2021; 6(65): eabf7235 Doi: 10.1126/sciimmunol.abf7235
Web of Science PubMed FullText FullText_MUG

 

** Wang, X; Ros, U; Agrawal, D; Keller, EC; Slotta-Huspenina, J; Dill, V; Shen, B; Shi, R; Herold, T; Belka, C; Mishra, R; Bassermann, F; Garcia-Saez, AJ; Jost, PJ MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF.
CELL DEATH DIFFER. 2021; Doi: 10.1038/s41418-021-00811-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Westphal, T; Gampenrieder, SP; Rinnerthaler, G; Balic, M; Posch, F; Dandachi, N; Hauser-Kronberger, C; Reitsamer, R; Sotlar, K; Radl, B; Suppan, C; Stoger, H; Greil, R Transferring MINDACT to Daily Routine: Implementation of the 70-Gene Signature in Luminal Early Breast Cancer - Results from a Prospective Registry of the Austrian Group Medical Tumor Therapy (AGMT)
BREAST CARE. 2021; Doi: 10.1159/000512467
Web of Science FullText FullText_MUG

 

** Yap, TA; Tan, DSP; Terbuch, A; Caldwell, R; Guo, C; Goh, BC; Heong, V; Haris, NRM; Bashir, S; Drew, Y; Hong, DS; Meric-Bernstam, F; Wilkinson, G; Hreiki, J; Wengner, AM; Bladt, F; Schlicker, A; Ludwig, M; Zhou, Y; Liu, L; Bordia, S; Plummer, R; Lagkadinou, E; de Bono, JS First-in-Human Trial of the Oral Ataxia Telangiectasia and RAD3-Related (ATR) Inhibitor BAY 1895344 in Patients with Advanced Solid Tumors.
Cancer Discov. 2021; 11(1):80-91 Doi: 10.1158/2159-8290.CD-20-0868 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zacharias, M; Absenger, G; Kashofer, K; Wurm, R; Lindenmann, J; Terbuch, A; Konjic, S; Sauer, S; Gollowitsch, F; Gorkiewicz, G; Brcic, L Reflex testing in non-small cell lung carcinoma using DNA-and RNA-based next-generation sequencing-a single-center experience
TRANSL LUNG CANCER R. 2021; Doi: 10.21037/tlcr-21-570 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Kricheldorf, K; Döhner, K; Stegelmann, F; Jost, PJ; Lang, F; Radsak, M; Hansen, R; Heuer, V; Röhrig, R; Brümmendorf, TH; Koschmieder, S; Isfort, S Challenges of patients with myeloproliferative neoplasms (MPN) in times of COVID: First results from a patient survey by the German Study Group for MPN.
LEUKEMIA RES. 2021; 110: 106646 Doi: 10.1016/j.leukres.2021.106646 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Cerroni, L; Schmidt, H; Beham-Schmid, C; Deinlein, T; Vallant, C; Richtig, E Talimogene laherparepvec can initiate plasma cell invasion into infiltrated melanoma lesions - a case series.
J Eur Acad Dermatol Venereol. 2021; 35(3):e209-e211 Doi: 10.1111/jdv.16922
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C Post San Antonio update-my top three abstracts!
MEMO-MAG EUR MED ONC. 2021; Doi: 10.1007/s12254-021-00718-0
Web of Science FullText FullText_MUG

 

** Woltsche, JN; Leithner, A; Smolle, MA; Szkandera, J; Maier, A; Liegl-Atzwanger, B; Smolle-Jüttner, FM Late metastasis in Ewing sarcoma.
Pediatr Blood Cancer. 2021; 68(4):e28791-e28791 Doi: 10.1002/pbc.28791
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Absenger, G; Pircher, A ASCO 2021-selection of personal highlights in early stage non-small cell lung cancer
MEMO-MAG EUR MED ONC. 2021; Doi: 10.1007/s12254-021-00770-w [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Absenger, G; Terbuch, A Unresectable pleural mesothelioma-hope or still an unmet medical need?
MEMO-MAG EUR MED ONC. 2021; Doi: 10.1007/s12254-021-00727-z
Web of Science FullText FullText_MUG

 

** Balic, M; Rinnerthaler, G; Bartsch, R Position Paper on the Value of Extended Adjuvant Therapy with Neratinib for Early HER2+/HR+ Breast Cancer
BREAST CARE. 2021; Doi: 10.1159/000518696 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Balihodzic, A; Barth, DA; Prinz, F; Pichler, M Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer.
Cancers (Basel). 2021; 13(5): 977 Doi: 10.3390/cancers13050977 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Ghafouri-Fard, S; Shoorei, H; Abak, A; Abbas Raza, SH; Pichler, M; Taheri, M Role of non-coding RNAs in modulating the response of cancer cells to paclitaxel treatment.
Biomed Pharmacother. 2020; 134: 111172-111172. Doi: 10.1016/j.biopha.2020.111172 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kaiser, M; Semeraro, MD; Herrmann, M; Absenger, G; Gerger, A; Renner, W Immune Aging and Immunotherapy in Cancer.
Int J Mol Sci. 2021; 22(13): 7016 Doi: 10.3390/ijms22137016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Laprovitera, N; Riefolo, M; Ambrosini, E; Klec, C; Pichler, M; Ferracin, M Cancer of Unknown Primary: Challenges and Progress in Clinical Management.
Cancers (Basel). 2021; 13(3): Doi: 10.3390/cancers13030451 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, E; Taucher, V; Lindenmann, J; Jost, PJ; Pichler, M Current Knowledge about Mechanisms of Drug Resistance against ALK Inhibitors in Non-Small Cell Lung Cancer.
Cancers (Basel). 2021; 13(4): Doi: 10.3390/cancers13040699 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, E; Taucher, V; Lindenmann, J; Pichler, M; Smolle-Juettner, FM Liquid biopsy in non-small cell lung cancer-current status and future outlook-a narrative review.
Transl Lung Cancer Res. 2021; 10(5): 2237-2251. Doi: 10.21037/tlcr-21-3 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Taheri, M; Barth, DA; Kargl, J; Rezaei, O; Ghafouri-Fard, S; Pichler, M Emerging Role of Non-Coding RNAs in Regulation of T-Lymphocyte Function.
Front Immunol. 2021; 12: 756042 Doi: 10.3389/fimmu.2021.756042 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Thomssen, C; Balic, M; Harbeck, N; Gnant, M St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer.
BREAST CARE. 2021; 16(2): 135-143. Doi: 10.1159/000516114 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Balic, M Best of SABCS 2020
MEMO-MAG EUR MED ONC. 2021; 14(3): 216-217. Doi: 10.1007/s12254-021-00744-y
Web of Science FullText FullText_MUG

 

Fallbericht

** Fabian, E; Kump, P; Schiller, D; Brcic, I; Gruber, C; Heitz, PU; Klöppel, G; Lipp, RW; Moinfar, F; Schöfl, R; Fickert, P; Krejs, GJ Clinical-Pathological Conference Series from the Medical University of Graz : Case No 173: A 77-year-old patient with adenocarcinoma of the prostate, liver metastases and watery diarrhea.
Wien Klin Wochenschr. 2021; 133(9-10):515-522 Doi: 10.1007/s00508-020-01791-x (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schmid, J; Prattes, J; Kaufmann-Bühler, AK; Riedl, JM Sampling site matters when testing for COVID-19 after total laryngectomy: a case report.
Wien Klin Wochenschr. 2021; 133(7-8):416-417 Doi: 10.1007/s00508-021-01826-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Zach, D; Ablasser, K; Kolesnik, E; Hoeller, V; Fruhwald, F; Prüller, F; Reiter, C; Beham-Schmid, C; Lipp, R; Rainer, PP; Zirlik, A; Wölfler, A; Verheyen, N Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.
ESC Heart Fail. 2021; 8(4):3397-3402 Doi: 10.1002/ehf2.13381 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Korrektur

** Wang, X; Ros, U; Agrawal, D; Keller, EC; Slotta-Huspenina, J; Dill, V; Shen, B; Shi, R; Herold, T; Belka, C; Mishra, R; Bassermann, F; Garcia-Saez, AJ; Jost, PJ Correction: MLKL promotes cellular differentiation in myeloid leukemia by facilitating the release of G-CSF.
Cell Death Differ. 2021; Doi: 10.1038/s41418-021-00826-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Allmendinger, F; Agrawal, D; Dietzen, M; Vosberg, S; Munkhbaatar, E; Branca, C; McGranahan, N; Jost, PJ RIPK3 downregulation in lung cancer alters the tumor immune micro-environment supporting tumor progression
ONCOL RES TREAT. 2021; 44: 51-52.
Web of Science

 

** Allmendinger, F; Agrawal, D; Dietzen, M; Vosberg, S; Munkhbaatar, E; McGranahan, N; Jost, PJ Necroptosis establishes an inflammatory tumor immune microenvironment acting as tumor suppressor in lung adenocarcinoma
ANN ONCOL. 2021; 32: S945-S945. Doi: 10.1016/j.annonc.2021.08.1788 [Poster]
Web of Science FullText FullText_MUG

 

** Aramberri, M; Munoz-Guglielmetti, D; Pesantez, D; Posch, F; Ay, C; Beato, C; Diaz-Pedroche, C; Font, C Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired versus outpatient) at diagnosis in the era of incidental events
THROMB RES. 2021; 200: S53-S54. [Onlinepräsentation]
Web of Science

 

** Dill, V; Wagner, C; Keller, E; Shoumariyeh, K; Odinius, T; Buschhorn, L; Suren, C; Hecker, J; Herhaus, P; Sandherr, M; Schmidt, B; Slotta-Huspenina, J; Bassermann, F; Hockendorf, U; Branca, C; Jilg, S; Jost, PJ RIPK3-dependent necroinflammation as a disease promoting mechanism in human myelofibrosis
ONCOL RES TREAT. 2021; 44: 161-161.
Web of Science

 

** Font, C; Posch, F; Ay, C; Aramberri, M; Pesantez, D; Munoz-Guglielmetti, D; Beato, C; Diaz-Pedroche, C Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
THROMB RES. 2021; 200: S66-S67. [Onlinepräsentation]
Web of Science

 

** Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, AL; Balic, M; Heibl, S; Zabernigg, A; Egle, D; Sandholzer, M; Roitner, F; Andel, J; Pichler, P; Hager, C; Hubalek, M; Knauer, M; Singer, CF; Greil, R Treatment landscape of HER2-positive metastatic breast cancer (MBC): Results from the Austrian AGMT_MBC-Registry
ANN ONCOL. 2021; 32: S487-S488. Doi: 10.1016/j.annonc.2021.08.566 [Poster]
Web of Science FullText FullText_MUG

 

** Gampenrieder, SP; Rinnerthaler, G; Tinchon, C; Petzer, AL; Suppan, C; Heibl, S; Voskova, D; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Andel, J; Hubalek, M; Knauer, M; Greil, R Does complete surgical removal of metastases in oligometastatic breast cancer improve survival? A matched-pair analysis of the AGMT_MBC-registry
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

** Jost, PJ; Munkhbaatar, E; Dietzen, M; Branca, C; McGranahan, N Clonal evolution in lung cancer highlights MCL-1 gains as therapeutic target in lung adenocarcinoma
J THORAC ONCOL. 2021; 16(4):S704-S704. [Poster]
Web of Science

 

** Koeberle, D; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; von der Heyde, E; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; Forstbauer, H; Fuxius, S; Schwaner, I; Losem, C; Hering-Schubert, C; Reichenbach, F; Arnold, D; Fritsch, R; Gerger, A; Hegewisch-Becker, S; Vogel, A; Wagner, AD; Winder, T; Prager, G; Stintzing, S Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: a multi-centric, multi-national, prospective, non-interventional study in Germany, Austria and Switzerland - BERING CRC
ONCOL RES TREAT. 2021; 44: 219-220.
Web of Science

 

** Lorch, M; Pfirrmann, M; Fabisch, C; Oberle, L; Kohn, D; Kohlbrenner, K; Brummendorf, TH; Burchert, A; Krause, SW; le Coutre, P; Hanel, M; Franke, GN; Stegelmann, F; Radsak, M; Kunzmann, V; Jost, PJ; Hofmann, WK; Hochhaus, A; Saussele, S Health-related quality of life (HRQoL) in CML-patients at diagnosis compared to general population
ONCOL RES TREAT. 2021; 44: 71-72.
Web of Science

 

** Moik, F; van Es, N; Posch, F; Di Nisio, M; Fureder, T; Preusser, M; Pabinger, I; Ay, C Evaluation of gemcitabine and platinum agents for the prediction of venous thromboembolism in patients with cancer: results from the Vienna Cancer and thrombosis Study
THROMB RES. 2021; 200: S68-S69. [Poster]
Web of Science FullText

 

** Nicolay, L; Avian, A; Pristauz-Telsnigg, G; Balic, M; Tamussino, K; Trutnovsky, G; Gold, D Vaginal Laser Therapy versus Hyaluronic Acid Suppositories in Women with genitourinary Menopausal Syndrome after Breast Cancer Treatment: A randomized controlled Trial
GEBURTSH FRAUENHEILK. Kongressabstracts. 2021; 81(06):E27-E27.-Gemeinsamen Jahrestagung der OEGGG und der BGGF; JUN 2-5, 2021; Virtuell, DEUTSCHLAND. Doi: 10.1055/s-0041-1730508 [Onlinepräsentation]
Web of Science FullText FullText_MUG

 

** Pichler, M MicroRNAs, precision oncology and innovative diagnostics in testicular germ cell tumor patients - an update
ONCOL RES TREAT. 2021; 44: 17-17.
Web of Science

 

** Rinnerthaler, G; Gampenrieder, SP; Tinchon, C; Petzer, AL; Suppan, C; Heibl, S; Voskova, D; Zabernigg, AF; Egle, D; Sandholzer, M; Singer, CF; Roitner, F; Andel, J; Hubalek, M; Knauer, M; Greil, R First-line treatment of hormone receptor positive metastatic breast cancer (MBC) in everyday practice: Results from the Austrian AGMT_MBC-Registry
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

** Sarif, Z; Dogan, A; Richtig, G; Fechner, H; Kreppel, F; Eberle, J Mcl-1 inhibition enhances the proapoptotic effects of vemurafenib in melanoma cells
EXP DERMATOL. ABSTRACT. 2021; 30(3):E106-E106.-47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF); MAR 4-6, 2021; Virtuell, DEUTSCHLAND. [Poster]
Web of Science

 

** Stintzing, S; Hubner, G; Schroder, J; Kisro, J; Welslau, M; Burkle, D; Gohler, T; Schmidt, B; Muller-Huesmann, H; Krammer-Steiner, B; von der Heyde, E; Reichenbach, F; Arnold, D; Gerger, A; Hegewisch-Becker, S; Vogel, A; Winder, T; Prager, G Encorafenib and cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: A multi-centric, multi-national, prospective, longitudinal, non-interventional study in Germany and Austria - BERING CRC
ANN ONCOL. 2021; 32: S116-S116. Doi: 10.1016/j.annonc.2021.05.113 [Poster]
Web of Science FullText FullText_MUG

 

** Suppan, C; Zhou, Q; Jahn, S; Graf, R; Klocker, EV; Terbuch, A; Kashofer, K; Posch, F; Gerritsmann, H; Dandachi, N; Heitzer, E; Balic, M Comparison of liquid biopsy and tissue based detection of PIK3CAmutations in HR positive metastatic breast cancer patients
CANCER RES. 2021; 81(4): [Poster]
Web of Science

 

** Terbuch, A; Absenger, G; Steinlechner, S; Jost, P; Wurm, R; Wohlkonig, C; Olschewski, H; Richtig, E; Koch, L; Winder, T; Woll, E; Gerger, A Autriche - AUsTrian Registry for Immune CHEckpoint inhibitors
ONCOL RES TREAT. 2021; 44: 229-229. [Poster]
Web of Science

 

** Vera-Ramos, JA; Stanzer, S; Pfeifer, V; Lopez-Garcia, P; Herbsthofer, L; Pieber, TR; Prietl, B Machine-learning based deep immunephenotyping for the identification of commonalities and differences between type 1 diabetes and other autoimmune diseases
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):230-230. [Poster]
Web of Science

 

** Vigier, M; Thorson, K; Andritsch, E; Farkas, C; Schwerdtfeger, A Physiological linkage during doctor-patient interactions in oncology
J PSYCHOSOM RES. 2021; 145: 110440--EAPM; JUN 8-11, 2021; AUSTRIA. Doi: 10.1016/j.jpsychores.2021.110440 [Onlinepräsentation]
Web of Science FullText FullText_MUG

 

© Med Uni Graz • Impressum